Prosci/B7-1 Recombinant Protein/92-581/0.05 mg,ProSci,,ProSci,prosci-inc,ProSci Incorporated,+,,Array.Array.Array蚂蚁淘厂家直采.

欢迎来到蚂蚁淘！（生命科学科研用品平行进口B2B商城）请登录免费注册询价篮

我的蚂蚁淘产品分类联系我们

ProSci Inc

主营：二抗，重组蛋白，细胞和组织裂解液，细胞涂片，组织切片，多肽

℡ 4000-520-616

产品名称：Prosci/B7-1 Recombinant Protein/92-581/0.05 mg

产品编号：92-581

市场价：¥4500.00

场地：美国(厂家直采)

产品分类：蛋白类>重组蛋白>其它重组蛋白>

联系QQ：1570468124

电话号码：4000-520-616

邮箱： info@ebiomall.com

美元价：$225.00

品牌： ProSci

公司：ProSci Inc

公司分类：

商品介绍

Specifications

SPECIES:	Mouse
SOURCESPECIES:	HumanCells
SEQUENCE:	Val38-Lys245
FUSIONTAG:	C-Fctag
TESTEDAPPLICATIONS:
APPLICATIONS:	ThisrecombinantproteincanbeusedforBIOLOGicalassays.Forresearchuseonly.

Properties

PURITY:	Greaterthan95%asdeterminedbyreducingSDS-PAGE. Endotoxinlevellessthan0.1ng/ug(1IEU/ug)asdeterminedbyLALtest.
PREDICTEDMOLECULARWEIGHT:	50.8kD
PHYSICALSTATE:	Lyophilized
BUFFER:	Lyophilizedfroma0.2umfilteredsolutionofPBS,pH7.4.Itisnotrecommendedtoreconstitutetoaconcentrationlessthan100ug/ml.DissolvethelyophilizedproteininddH2O.
STORAGECONDITIONS:	Lyophilizedproteinshouldbestoredat-20˚C,thoughstableatroomtemperaturefor3weeks. Reconstitutedproteinsolutioncanbestoredat4-7˚Cfor2-7days. Aliquotsofreconstitutedsamplesarestableat-20˚Cfor3months.

AdditionalInfo

ALTERNATENAMES:	T-lymphocyteactivationantigenCD80,ActivationB7-1antigen,B7,CD80
ACCESSIONNO.:	Q00609

Background

ClusterofDifferentiation80,alsocalledB7-1,isamemberofcellsurfaceimmunoglobulinsuperfamilywhichplayskey,yetdistinctrolesintheactivationofTcells.ItistheligandfortwodifferentproteinsontheTcellsurface:CD28andCTLA-4.StudieshaveshownthatCTLA-4bindsmostlytoCD80.Thestructurepresentstwoextracellulardomains:amembranedistalvariable-likedomain(IgV)andamembraneproximalIgconstant-likedomain(IgC)alongwithanintracellulardomain.BothIgVandIgCconsistofanti-parallelbetasandwichesjoinedbyashortlinkerregion.CD80ismostlyexpressedonthesurfaceofantigen-presentingcellsincludingactivatedBcells,macrophagesanddendriticcells.

品牌介绍

ProSci Inc.始终开放以支持研究需求，同时确保我们员工的健康和安全。ProSci拥有广泛的冠状病毒SARS-CoV-2 重组蛋白和抗体产品组合，并将继续积极开发新的冠状病毒产品。此外，ProSci的定制抗体服务也保持开放状态，以支持研究团体开发研究工具，诊断，疗法和疫苗。